Transgender hormone therapy (male-to-female) males is associated with higher serum estrogen. Both estrogen and testosterone help to stimulate bone formation, especially during puberty. Estrogen is the predominant sex hormone that slows bone loss, even in men. In spite of the induction of breast development, transgender women who undergo HRT do not have an increased risk of breast cancer. Only a handful of cases of breast cancer have ever been described in transgender women who have undergone male-to-female HRT. This is in accordance with research in cisgender men in which gynecomastia has been found not to be associated with an increased risk of breast cancer,
Fraternal birth order and male sexual orientation support a prenatal origin to sexual orientation development in men and indicate that the fraternal birth order effect is probably the result of the mother's body's “memory” for both male births as well as male gestations (i.e., every instance of being pregnant with a male fetus). So even if a male fetus was not carried to term, he still increases the likelihood of homosexuality in any subsequent male fetuses gestated by the same mother. The existence of the fraternal birth order effect on male sexual orientation has been confirmed many times. One approach for establishing the ubiquity of this effect